Background Patients in a minimally conscious state (MCS) show restricted self or environment awareness but are unable to communicate consistently and reliably. Therefore, better understanding of cerebral noxious processing in these patients is of clinical, therapeutic, and ethical relevance.
Introduction
A persistent vegetative state (PVS) is defi ned by wakefulness without awareness of self or the environment, 1 whereas patients in a minimally conscious state (MCS) show some evidence of self and environmental awareness. 2 However, the carers of patients who are minimally conscious have diffi culties in assessing the patients' level of conscious pain perception through their behaviour. Moreover, there are no guidelines on pain treatment in patients in MCS. 3 Noxious stimulation is a routine clinical procedure for the bedside assessment of consciousness in patients who are severely brain damaged. Noxious stimulation is also part of the commonly used coma scales, such as the Glasgow coma scale (GCS), 4 the reaction level scale, 5 the Innsbruck coma scale, 6 the Edinburgh 2 coma scale, 7 and the coma recovery scale. 8 The study of cerebral processing of noxious stimulation in these patients is also of clinical, therapeutic, and ethical relevance. 9 We have previously reported on the cortical responses of patients in PVS to similar noxious somatosensory stimuli by use of ¹⁵O-radiolabelled water PET, 10 and found that the only areas that signifi cantly responded to noxious stimulation in patients in PVS were the brainstem, contralateral thalamus, and primary somatosensory cortex (S1). Here, we used an identical set-up to study fi ve patients who are in MCS and compared the results with those from patients in PVS and 15 healthy controls.
Methods

Participants
Five non-sedated patients in MCS (4 men; mean age 49 [SD 22 ] years, range 18-74 years), 15 non-sedated patients in PVS (12 men; mean age 48 [17] years, range 19-75 years), and 15 healthy volunteers (8 male; mean age 40 [9] years, range 19-64 years) were studied prospectively. Table 1 shows the demographic data of the patients in MCS. The aetiologies of the patients in PVS were: cardiorespiratory arrest (n=5), diff use axonal injury (n=3), drugs overdose (n=2), prolonged respiratory insuffi ciency (n=2), encephalitis with diff use white matter lesions (n=2), and carbon monoxide intoxication (n=1). Clinical diagnoses were made on the basis of repeated, standardised evaluation 11 and conformed to international criteria for PVS 12 and MCS. 13 Patients were assessed four times by trained and experienced assessors (SL and CS): 1 week and 1 day before scanning, the day of the scan, and 1 week after the scan. None of the patients in MCS showed localisation in response to noxious stimuli and none of the patients in PVS showed normal fl exion or withdrawal in response to noxious stimuli. Mean GCS 4 on admission were 6 (SD 5) points for the patients who were minimally conscious and 5 (3) points for the patients in PVS. All patients had preserved pupillary, corneal, and vestibulo-ocular refl exes. Assessment of median nerve sensory conduction velocity and somatosensory evoked potential excluded peripheral nerve, plexus, or spinal cord lesions. Short latency auditory evoked potentials showed preserved pontine and midbrain functions in all patients.
Procedures
Patients in MCS were scanned a mean of 57 (SD 33) days after admission and patients in PVS 36 (9) days after admission. Patients were scanned during awake periods, as shown by simultaneous polygraphic recordings (electroencephalogram and electro-oculogram). Throughout the procedure, patients were monitored by a senior anaesthetist (MEF), assisted by an intensive care physician. Written, informed consent was obtained from the people with legal responsibility for the patients and from all controls personally. Stimulation was kept at the minimum duration (6×70 s) and minimum intensity needed for PET. Stimulation intensities were increased to the point where all components of the somatosensory evoked potentials showed maximum amplitude; 14 the stimulation intensity was then kept constant throughout the experiment. Electrical stimulation of the median nerve at the intensity used was rated as highly unpleasant to painful by the controls. 10 The stimulation intensities used in non-communicative patients were lower than those used routinely when somatosensory evoked potentials are recorded at an intensive care unit. 15 The study was approved by the ethics committee of the Faculty of Medicine of the University of Liège and done in accordance with the Declaration of Helsinki 16 and the International Association for the Study of Pain (IASP) Ethical Guidelines for Pain Research in Humans. 17 Changes in regional cerebral blood fl ow were measured with ¹⁵O-radiolabelled water PET, as described elsewhere. 10 Data acquisition in patients in MCS started 24 months after the study in patients in PVS. 10 Scans were done during rest and electrical stimulation of the left-sided and right-sided median nerve (0·2 ms squarewave pulses at 5·1 Hz at the wrist). We chose bilateral median nerve stimulation because this meant that both hemispheres were recruited in patients with severe brain injury. The conditions of each test were repeated three times (except in one patient, in whom only two scans could be obtained for left-sided and two scans for right-sided noxious stimulation). The order or presentation was pseudorandomised for all patients. Haemodynamic parameters were monitored, and 
Statistical analysis
PET data were realigned, spatially normalised, smoothed, and analysed with statistical parametric mapping. Because SPM is a more powerful voxel-based statistical method with more precise anatomical validity, it was preferred over the region-of-interest approach. A smoothing kernel of full width at a half maximum of 16 mm was chosen owing to the severely damaged brains of the patients in MCS or PVS. The smoothing was identical to that used in our previous study. 10 Data obtained during left-sided noxious stimulation and at rest were fl ipped, as reported previously. 10 A random eff ects analysis 18 identifi ed the areas of the brain that were activated during noxious stimulation. We calculated one contrast between stimulation and rest per patient, which accounts for the within-patient component of the variance. We used these contrast images in a second design matrix that took into account the between-patient component of the variance and separated the data into three groups (controls, patients in PVS, and patients in MCS). The fi rst two contrasts searched for brain activation in response to noxious stimulation in controls and patients in an MCS. We also looked for the group interaction ([controls-patients in MCS] × condition [stimulation-rest]) to search for areas that were less activated in patients in MCS than in healthy controls. 19 A second group interaction was done ([patients in MCS-patients in VS]×condition [stimulation-rest]) to search for the areas that were more activated in patients in MCS than patients in PVS. By use of reversed T contrasts we also looked for and compared deactivations during noxious processing with baseline in controls and patients in MCS. The results from the patients were masked inclusively by the results from the controls (uncorrected p<0·05). The results from controls and comparisons between patient populations were thresholded at a whole-brain false discovery rate (FDR)-corrected p value of less than 0·05. 20, 21 Results from patients in MCS were thresholded at p values less than 0·05 and corrected for multiple comparisons with FDR at the whole-brain level or in a small volume (spheres with 10 mm radii) centred on the peak voxels of interest that were identifi ed in controls.
Finally, we did a psychophysiological analysis, as previously described. 10 Our previous analysis was of the modulation between S1 and the rest of the brain in controls and patients. The fi rst analysis looked for preserved modulation between S1 and the rest of the brain in patients in MCS compared with controls, by way of a conjunction approach-a conjunction analysis requires that all tested comparisons are individually signifi cant. 22 Here, we looked for brain regions that were signifi cantly modulated by S1 in patients in MCS and controls. A second analysis looked for diff erences between patients in MCS and controls. Finally, we searched for diff erences of S1 functional connectivity between patients in MCS or patients in PVS. Results were masked inclusively by controls results (uncorrected For more on statistical parametric mapping (SPM) see www.fi l.ion.ucl.ac.uk/spm p<0·05). All results from psycho-physiological interactions were thresholded at a whole-brain FDRcorrected p value of less than 0·05.
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Results
In the controls, noxious stimulation resulted in the subjective experience of pain and increased regional cerebral blood fl ow in several areas, including the thalamus, striatum, contralateral S1, secondary somatosensory or insular cortices, superior temporal, posterior, parietal, posterior cingulate, prefrontal, and anterior cingulate cortices (table 2 and fi gure). Compared with baseline, deactivations could also be found in the posterior cingulate and precuneus and medial prefrontal cortices (table 2) . Patients who were minimally conscious also showed signifi cant activation in all the areas activated in the controls (table 2, webfi gure), although the pattern of activation was lateralised and with less spatial extent. The total extent of stimulus-induced cerebral activation (at an uncorrected p value of <0·001) in controls and patients in MCS was 4395 and 1471 voxels, respectively, taking into account the diff erences in the numbers of patients. However, the interaction analysis did not identify any voxel that was signifi cantly less activated in the patients in MCS compared with controls. During noxious stimulation, the posterior cingulate or precuneus and medial prefrontal cortices also showed deactivation in patients in MCS, but there was no diff erence in deactivation after correction for multiple comparisons. However, deactivations in patients in MCS were signifi cantly less pronounced than in controls (table 2) .
Compared with patients in PVS, patients who were minimally conscious showed signifi cantly greater activation in the S1, secondary somatosensory cortex or insula, anterior cingulate cortex, and posterior parietal and dorsolateral prefrontal cortices (table 3) . No voxels were signifi cantly less activated in patients in MCS compared with patients in PVS.
Finally, psychophysiological interaction analysis revealed preserved modulation between S1 and a large set of associative areas, including the high order frontoparietal cortices, in patients in MCS (table 4) . Compared with controls, patients in MCS had impaired connectivity in the posterior cingulate or precuneus and in the medial prefrontal cortices. When patients in MCS were compared with patients in PVS, functional connectivity between the S1 and the lateral and medial frontoparietal areas was signifi cantly higher in patients in MCS than those in PVS.
Discussion
Pain is a subjective experience. 23 By defi nition, patients in MCS are unable to consistently and reliably communicate their experiences, and their behavioural responses to noxious stimulation are often diffi cult to interpret. Even if some patients in MCS can correctly answer yes or no questions at a level above chance, a question such as, "Are you in pain?" might not elicit a reliable response. The behavioural assessment of motor or autonomic signs (ie, respiratory frequency, heart rate, blood pressure, pupillary diameter, and skin conductance) are not reliable markers of the conscious perception of pain, as shown in studies done in general anaesthesia. 24 The evaluation and treatment of pain is therefore an important clinical and ethical problem in patients in MCS. In this context, functional neuroimaging can objectively measure changes in brain function during noxious stimulation in these patients. Indeed, several authors have stressed the need for brain imaging studies of pain processing in patients who are in altered states of consciousness. 12, [25] [26] [27] The study of cerebral responses to painful stimuli in patients with altered states of consciousness can also help to understand pain processing in healthy patients. The role of diff erent areas of the brain in pain processing is only partially understood, and the neural representation of the brain is thought to be both specifi c and integrated. In summary, the sensory-discriminative component of pain is thought to depend on primary and secondary somatosensory cortices, and the aff ectivemotivational on the anterior cingulate cortex and prefrontal areas-the insular cortex has an intermediate role. [29] [30] [31] [32] In healthy volunteers, electrical stimulation of the median nerve was perceived as highly unpleasant to painful and activated areas of the brain that were previously described in pain imaging studies-the pain matrix. 30, 31, 33 A similar set of cortical and subcortical areas was activated during noxious stimulation in patients in MCS and in healthy controls. The only areas that were not signifi cantly activated in patients in MCS were the posterior cingulate cortex and the striatum, but direct comparison of the activation of these areas between controls and patients in MCS did not show a signifi cant diff erence. We cannot exclude the possibility that there is a diff erence in the cerebral processing of painful stimuli between patients in MCS and controls because the activation volumes were greater and more bilateral in controls than in patients in MCS; however, this might also be because of the few patients in MCS who were scanned. Finally, when patients in MCS were compared with controls no area was signifi cantly less activated, whereas the activation of a large number of associative areas during noxious stimulation was not seen in any of the patients in PVS. 10 Indeed, the patients in MCS not only had activation in the contralateral thalamus and S1, as did the patients in PVS, but also in high-order associative areas, including contralateral secondary somatosensory and posterior insular cortices, posterior parietal and dorsolateral prefrontal cortices, and anterior cingulate cortex. The whole cortical pain matrix was signifi cantly more activated in patients in MCS than in patients in PVS when both populations were compared directly. In patients in MCS, functional connectivity between the primary somatosensory cortices and lateral frontoparietal cortices was similar to the functional connectivity in the controls. This frontoparietal network connectivity was signifi cantly stronger in patients in MCS than in patients in PVS. These fi ndings indicate that patients in MCS might show an elaborate and integrated level of noxious processing, which contrasts with previous fi ndings in patients in PVS. 10 The time lapse between the study in patients in PVS and the current study in patients in MCS makes unbiased comparisons diffi cult. However, the infrastructure (scanner, scanning protocol, and painful stimulation methodology) was matched for both studies.
Peak pain-related activation was found in the secondary somatosensory or posterior insular cortex in patients in MCS and in controls. The insular cortex is thought to be important for pain perception because it was activated in brain imaging studies on pain, 31, 34 and direct electrical stimulation of the insular cortex induces the sensation of pain in human beings. 35 However, a recent PET study showed activation of the insular cortex during general anaesthesia in healthy volunteers; 36 the authors interpreted these results as brain autonomic responses evoked by the noxious stimulation. In patients in MCS, however, activation of the insular cortex in response to noxious stimulation was associated with brain activity and functional connectivity in several brain areas that are involved in both the sensory and limbic aspects of pain processing. [29] [30] [31] More specifi cally, the activation of highorder frontoparietal cortices has been repeatedly associated with the conscious perception of external stimuli in visual 37, 38 and somatosensory 28, 39 modalities. Even if the neural correlates of conscious perception and pain processing need to be fully elucidated, 40 the coactivation of specialised sensory cortices and frontoparietal areas seems both necessary and suffi cient to generate conscious perception. 41 Although brain imaging is not a shortcut to subjectivity, we interpret the brain activation and functional connectivity patterns seen in patients in MCS as likely to show conscious perception of noxious stimuli.
Among the commonly identifi ed cerebral areas in human neuroimaging studies, the anterior cingulate and insular cortices show particularly consistent responses during the pain. 42 Moreover, the level of activation in the anterior cingulate cortex correlates with pain intensity scores. 30, 42 In brain imaging studies, activation of the anterior cingulate cortex was associated with the aff ectivemotivational components of pain perception, 43 and in the processing of stimulus intensity 44 and stimulus awareness. 28, 44 The activation of the anterior cingulate cortex in response to noxious stimuli in patients in MCS is important because it suggests that they might also have pain aff ect. The impaired deactivation and functional connectivity seen in areas of the default network (ie, the posterior cingulate or precuneus and medial prefrontal cortices), 45 which are thought to be involved in self-related processes, 46 could show preserved but diff erent-fromnormal perception of pain in patients in MCS.
signifi cant diff erences could be shown. We only did analyses at the group level; hence, our results do not imply that none of the patients in PVS could activate a large number of brain areas in response to noxious stimulation or that all patients in MCS do so-even if the random eff ects analyses we used took within-patient and between-patient variability into account. Unfortunately, the ¹⁵O-radiolabelled water PET technique does not enable us to identify reliably activation maps in individual patients. Functional MRI can tackle this problem because many more scans can be acquired per patient; these studies are currently ongoing. Our fi ndings are relevant for the understanding of pain processing and to ethical discussions but do not provide suffi cient evidence to guide the clinical management of individual patients. Variability in pain processing is expected between individuals in heterogeneous populations of patients. Although our study also stresses the need to distinguish at the bedside patients in MCS from patients in PVS, several studies have shown that misdiagnosis is common between these populations of patients. 27 The evidence is not suffi cient to choose not to treat potentially painful conditions in patients in PVS. Analgesic intervention in these patients is also desirable to prevent potentially damaging defensive hormonal reactions (eg, adrenal stress hormones), despite the possible absence of pain. Controlled trials that report objective outcomes, such as the absence of negative complications and survival, would enable assessment of the clinical appropriateness of analgesia in patients in PVS or MCS.
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